Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
22.18
+0.57 (2.61%)
May 5, 2026, 11:42 AM EDT - Market open
Assertio Holdings Employees
Assertio Holdings had 53 employees as of December 31, 2025. The number of employees decreased by 5 or -8.62% compared to the previous year.
Employees
53
Change (1Y)
-5
Growth (1Y)
-8.62%
Revenue / Employee
$2,239,868
Profits / Employee
-$573,113
Market Cap
143.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 53 | -5 | -8.62% |
| Dec 31, 2024 | 58 | 5 | 9.43% |
| Dec 31, 2023 | 53 | 23 | 76.67% |
| Dec 31, 2022 | 30 | 11 | 57.89% |
| Dec 31, 2021 | 19 | -8 | -29.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
| Cumberland Pharmaceuticals | 93 |
| Journey Medical | 58 |
| Cardiol Therapeutics | 18 |
ASRT News
- 1 day ago - Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics - Business Wire
- 5 days ago - Assertio and Garda Mutually Agree to Extend Tender Offer Deadline - Business Wire
- 13 days ago - Assertio Provides Update on Garda Therapeutics Tender Process - Business Wire
- 26 days ago - Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio - Business Wire
- 26 days ago - Assertio Announces Agreement to be Acquired by Garda Therapeutics - Business Wire
- 4 weeks ago - Top 2 Health Care Stocks That May Implode In April - Benzinga
- 7 weeks ago - Assertio Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Assertio Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire